Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Sumit Parmar; Julia Carolin Stingl; Ariana Huber-Wechselberger; Alexander Kainz; Wilfried Renner; Uwe Langsenlehner; Peter Krippl; Jürgen Brockmöller; Elisabeth Haschke-Becher

doi:10.1186/bcr2894

Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

Sumit Parmar
, Julia Carolin Stingl
, Ariana Huber-Wechselberger
, Alexander Kainz
, Wilfried Renner
, Uwe Langsenlehner
, Peter Krippl
, Jürgen Brockmöller
, Elisabeth Haschke-Becher^* (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsinstitut für Medizinisch-Chemische Labordiagnostik

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

38 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	R57
Fachzeitschrift	BREAST CANCER RESEARCH
Jahrgang	13
Ausgabenummer	3
DOIs	https://doi.org/10.1186/bcr2894
Publikationsstatus	Veröffentlicht - 2011

Zugriff auf Dokument

10.1186/bcr2894

Dieses zitieren

@article{cf6abca286c54fc1bde2b3e0f950099f,

title = "Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.",

keywords = "UDP-GLUCURONOSYLTRANSFERASE 2B7, HUMAN LIVER-MICROSOMES, ENDOTHELIAL GROWTH-FACTOR, GENETIC POLYMORPHISMS, MYCOPHENOLIC-ACID, HORMONE-THERAPY, UGT2B7, GLUCURONIDATION, MORPHINE, PHARMACOKINETICS",

author = "Sumit Parmar and Stingl, \{Julia Carolin\} and Ariana Huber-Wechselberger and Alexander Kainz and Wilfried Renner and Uwe Langsenlehner and Peter Krippl and J{\"u}rgen Brockm{\"o}ller and Elisabeth Haschke-Becher",

note = "Christian Doppler Clinic, Private Paracelsus Medical University Salzburg, Ignaz Harrerstrasse 79, Salzburg, 5020, Austria ",

year = "2011",

doi = "10.1186/bcr2894",

language = "English",

volume = "13",

pages = "R57",

journal = "BREAST CANCER RESEARCH ",

issn = "1465-5411",

publisher = " BioMed Central",

number = "3",

}

TY - JOUR

T1 - Impact of UGT2B7 His268Tyr polymorphism on the outcome of adjuvant epirubicin treatment in breast cancer.

AU - Parmar, Sumit

AU - Stingl, Julia Carolin

AU - Huber-Wechselberger, Ariana

AU - Kainz, Alexander

AU - Renner, Wilfried

AU - Langsenlehner, Uwe

AU - Krippl, Peter

AU - Brockmöller, Jürgen

AU - Haschke-Becher, Elisabeth

N1 - Christian Doppler Clinic, Private Paracelsus Medical University Salzburg, Ignaz Harrerstrasse 79, Salzburg, 5020, Austria

PY - 2011

Y1 - 2011

KW - UDP-GLUCURONOSYLTRANSFERASE 2B7

KW - HUMAN LIVER-MICROSOMES

KW - ENDOTHELIAL GROWTH-FACTOR

KW - GENETIC POLYMORPHISMS

KW - MYCOPHENOLIC-ACID

KW - HORMONE-THERAPY

KW - UGT2B7

KW - GLUCURONIDATION

KW - MORPHINE

KW - PHARMACOKINETICS

U2 - 10.1186/bcr2894

DO - 10.1186/bcr2894

M3 - Original Article

C2 - 21658222

SN - 1465-5411

VL - 13

SP - R57

JO - BREAST CANCER RESEARCH

JF - BREAST CANCER RESEARCH

IS - 3

ER -